NAADP mediates ATP-induced Ca2+ signals in astrocytes by Barceló Torns, Miquel et al.
 "This is the accepted version of an article published in FEB Letters, Vol. 585, no. 14 (2011) available at DOI: 10.1016/j.febslet.2011.05.062
© 2011. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ "

 
NAADP mediates ATP-induced Ca2+ signals in astrocytes 
 
Miquel Barceló-Tornsa, Alexander M. Lewisb, Albert Guberna, David Barnedaa, Duncan 
Bloor-Youngb, Fernado Picatostea,  Grant C. Churchillb, Enrique Claroa and Roser Masgraua 
 
aInstitut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat 
Autònoma de Barcelona, E-08193 Bellaterra, Catalonia, Spain. bDepartment of 
Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, United Kingdom. 
 
Address correspondence to: Roser Masgrau, Institut de Neurociències and Dept. Bioquímica i 
Biol. Mol., Universitat Autònoma de Barcelona, Edifici M, Campus Bellaterra, E-08193 
Cerdanyola del Vallès, Barcelona, Catalonia, Spain. Tel: +34 935814278,  
Fax: +34 935811573, e-mail: roser.masgrau@uab.cat 
  
Abstract 
Intracellular Ca2+ signals provide astrocytes with a specific form of excitability that enables them to 
regulate synaptic transmission. In this study, we demonstrate that NAADP-AM, a membrane-
permeant analogue of the new second messenger Nicotinic Acid-Adenine Dinucleotide Phosphate 
(NAADP), mobilizes Ca2+ in astrocytes and that the response is blocked by Ned-19, an antagonist of 
NAADP signalling. We also show that NAADP receptors are expressed in lysosome-related acidic 
vesicles. Pharmacological disruption of either NAADP or lysosomal signalling reduced Ca2+ 
responses induced by ATP and endothelin-1, but not by bradykinin. Furthermore, ATP increased 
endogenous NAADP levels. Overall, our data provide evidence for NAADP being an intracellular 
messenger for agonist-mediated calcium signalling in astrocytes. 
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After several years of intense research, classical paradigms on brain function have been 
challenged by data that demonstrate an active and key role for glial cells [1,2].  Based on Ca2+ signals 
rather than action potentials, astrocytes are excitable cells that assimilate information from different 
inputs and send instructive chemical signals to neighbouring cells. In this concept of an astrocyte-
neuron network (or tripartite synapse), astrocytes sense neuronal activity as they express a wide range 
of functional neurotransmitter receptors capable of inducing  intracellular Ca2+ increases. In turn, 
astrocytic Ca2+ increases trigger the release of many chemical transmitters [3], such as ATP, that 
signal back to neurons, modulating their excitability, or to astrocytes, reinforcing the Ca2+ wave and 
allowing transfer of information between them. Interestingly, although receptor-mediated Ca2+ signals 
in astrocytes mainly depend on stimulation of phospholipase C, inositol 1,4,5-triphosphate (IP3) 
production, and Ca2+ release from the endoplasmic reticulum, they differ in magnitude and spatial- 
and temporal characteristics, which indicates that they are not equally capable of stimulating 
gliotransmitter release.   
NAADP is the most recently discovered and most potent Ca2+ mobilizing second messenger [4,5] 
and has been shown to control  cellular events such as insulin release from pancreatic β cells [6] or 
fertilization [7]. The main features of NAADP are its ability to mobilize Ca2+ from lysosome-related 
acidic organelles and its bell-shaped concentration-effect curve [4,6,8]. NAADP is also considered as a 
Ca2+ trigger signal in many cell systems. The molecular identity of NAADP receptors in mammals is 
still unresolved, although two-pore channels (TPC) have been demonstrated to be endogenous NAADP 
receptors in sea urchins and to act as NAADP-activating Ca2+ channels when they are overexpressed in 
particular mammalian cell lines [9,10]. It has also been suggested that transient receptor potential-
mucolipin 1 channel (TRP-ML1), TRPM-2  and ryanodine receptors act as a NAADP-sensitive 
channels [10].  
Widespread distribution of NAADP binding sites in the brain [11] and glutamate-induced NAADP 
increases in whole-brain tissue [12] support a role for this second messenger in the brain. But to date, 
there is no evidence for NAADP as an intracellular second messenger in astrocytes.  
 
  
2. Materials and Methods 
2.1. Materials 
[32P]Nicotinamide adenine dinucleotide ([32P]NAD) (800 Ci/mmol) was purchased from Perkin-
Elmer; lysotracker red, penicillin and streptomycin from Invitrogen, and endothelin-1 (human, 
porcine), bafilomycin A1 and 2-aminoethoxydiphenylborane (2-APB) from Tocris. Ned-19 and 
NAADP-AM were synthesized in house. All other compounds were from Sigma.  
 
2.2. Tissue Culture 
 Primary cultures of cortical astrocytes were prepared from 1-day-old Sprague-Dawley rats following 
the protocol described previously [13]. Cells were plated into 35-mm dishes containing a coverslip at 
a density of 0.2 x 106 viable cells/ml in DMEM supplemented with 10% fetal bovine serum (FBS), 50 
units/ml penicillin and 50 µg/ml streptomycin. The cultures were incubated at 37 ºC in a humidified 
atmosphere of 5% CO2/95% air and used at 7- 20 days in vitro. Additionally, secondary cultures of 
cortical astrocytes were made by seeding cells in flasks. When these cells reached confluence, 
microglia and oligodendrocytes were removed by mechanically shaking and astrocytes were seeded 
onto coverslips. 
 
2.3. Ca2+ Imaging 
 Astrocytes were incubated with fura-2/AM at 4 µM in Krebs buffer with the following composition 
(in mM): 119 NaCl, 4.75 KCl, 5 NaHCO3, 1.2 MgSO4, 1.18 KH2PO4, 20 Hepes, 1.3 CaCl2 and 5 
glucose at pH 7.4. After 1 h, cells were washed and coverslips mounted in a static chamber on an 
inverted Nikon TE2000U microscope, and Ca2+ imaging performed as previously described [14]. 
Cells were incubated with antagonists for 20 min before stimulation. Cytosolic Ca2+ concentration is 
given as the ratio of fluorescence obtained exciting cells at 340 and 380 nm (F340:F380 ratio). 10-20 
cells from at least three independent cultures were analysed. Data are expressed as mean ± SEM. 
 
2.5. Immunohistochemistry and Confocal Microscope 
Cells cultured on glass coverslips were loaded with 100 µM Ned-19 for 1 h at 37 oC and during the 
last 10 min 500 nM lysotracker red was added. Coverslips were mounted in a static chamber on a 
LSM 510 Meta confocal microscope (Zeiss) using a 40 x oil immersion lens. Lysotracker red 
fluorescence was visualized at 568 nm excitation (red, krypton laser) and emission collected with a 
590 nm long-pass filter. Ned-19 fluorescence was monitored with excitation at 355 nm (UV, argon 
laser) and emission collected with a band-pass filter of 415 ± 30 nm. Image analysis was done with 
ImageJ 1.43r (Wayne Rasband, NIH), using Image CorrelationJ plugin (www.gcsca.net 
/IJ/ImageCorrelationJ.html).  
2.7. [32P]NAADP synthesis and NAADP radiobinding assay 
[32P]NAADP was synthesized in a two-step reaction as described previously [15]. To determine 
endogenous NAADP levels, we used a radioreceptor binding assay extensively described by us [15]. 
In brief, cells cultured in 60-mm dishes were stimulated with ATP or vehicle and NAADP content of 
samples was quantified using a competitive binding curve made with known concentrations of 
NAADP. Data were normalized to calculate the fold increases over basal NAADP levels. 
 
3. Results  
3.1. NAADP is an intracellular second messenger in astrocytes 
 To study whether NAADP is an endogenous molecule in astrocytes, we first determined 
intracellular NAADP levels. Our data showed that at rest conditions NAADP was present at very low 
concentrations, 5.09 ± 0.93 pmol/mg protein ( n = 20). These results are in agreement with published 
results of resting NAADP levels in different tissues that range from 0.1 to 48 pmol/mg protein and 
particularly with resting NAADP levels detected in whole-brain cell suspensions (8.3 pmol/mg 
protein) [12]. 
We also investigated the presence of NAADP receptors in astrocytes. As their nature is not 
completely and unequivocally resolved in mammalian cells and the presence of multiple binding sites 
for NAADP has been suggested in the brain [11], we considered that Ned-19, a fluorescent highly 
selective NAADP receptor antagonist [16], was the best tool for such studies. Figure 1 shows that 
Ned-19 binding sites, presumably the NAADP receptors, are present in intact astrocytes with a 
punctate distribution and with a very high degree of colocalization with labelling of acidic organelles 
with lysotracker (correlation coefficient of 0.62). It is worth noting that not all acidic vesicles stained 
with lysotracker express NAADP receptors, stressing the heterogeneity of these organelles. 
Conversely, a very small percentage of the punctate staining of NAADP receptors did not colocalize 
with lysotracker, in agreement with results suggesting that the putative NAADP TPC1 partly localizes 
in endosomes  [10]. On the other hand, lack of complete overlap demonstrate that the colocalization is 
not an artefact of light bleed from one channel to the other. 
We then investigated whether increases in the NAADP concentration induced Ca2+ responses by 
adding NAADP-AM, a cell permeable acetoxymethyl ester of NAADP, to astrocytes loaded with 
fura-2. NAADP-AM is a less invasive tool than micro-injection of NAADP or caged-NAADP and it 
has been shown to be effective in numerous mammalian cell types [17]. The addition of 50 nM or 100 
nM NAADP-AM produced complex Ca2+ responses with a prominent oscillatory component (Fig. 
2A). Consistent with reports in other cell types [4,6], higher NAADP-AM concentrations induced 
smaller responses, generating a “bell-shaped” concentration-response curve (Fig. 2B). NAADP-AM-
elicited Ca2+ responses were detected from 2 to 20 min after addition of NAADP-AM and were 
abolished by pre-incubation of cells with Ned-19 (Fig. 2C), which can be considered diagnostic for 
NAADP responses.  Conversely, the lysosomal disruptor compound glycyl-L-phenylalanine 2-
naphthylamide (GPN) inhibited most NAADP-AM responses (no cells responded to NAADP-AM in 
five experiments and 38 % of cells responded in one experiment) (Fig.2C) demonstrating that 
intracellular NAADP acts on specific receptors mainly localized in lyosome-related Ca2+ stores. On 
the other hand, extracellular addition of NAADP also induced intracellular Ca2+ increases at high 
concentrations as previously reported [18,19]. Responses were heterogeneous. For example, some 
astrocytic cultures did not respond to 1 mM NAADP, others had 28 % of cells showing quick and 
small  Ca2+ responses, and in other cultures, 66 % of cells exhibited slow and high Ca2+ increases 
(Figure 1SA and B). Moreover, Ca2+ responses induced by extracellular NAADP were not inhibited 
by Ned-19 in any tested culture (Fig. S1C), demonstrating that extra- and intracellular NAADP act on 
different molecular targets in astrocytes. 
Taken together, these results suggest that intracellular NAADP is an endogenous molecule in 
astrocytes able to induce Ca2+ release by the activation of receptors present mainly in acidic lysosome-
related vesicles. 
 
3.2. NAADP and acidic organelles mediate agonist-induced Ca2+ responses 
We next investigated whether the NAADP signalling pathway could be activated by extracellular 
stimuli in astrocytes. In particular, we analysed the Ca2+ responses elicited by ATP, endothelin-1 and 
bradykinin, agonists traditionally linked to phospholipase C activation and IP3-mediated Ca2+ release 
from the endoplasmic reticulum. Endothelin-1, however, has also been reported to increase NAADP 
levels in smooth muscle [20].  
The addition of 100 μM ATP, 10 nM endothelin-1 or 1 μM bradykinin to astrocytes elicited Ca2+ 
responses characterized by an initial peak followed by a plateau phase (Fig. 3). The latter was more 
sustained if induced by endothelin-1, and in all cases it was sensitive to extracellular Ca2+ (Fig. 4) 
[21,22]. To determine the participation of NAADP signalling, we first pre-treated the cells with 100 
μM Ned-19 to block the NAADP receptor. As shown in Fig. 3A and Fig. 3B, Ned-19 reduced the 
initial peak of the Ca2+ responses induced by ATP and endothelin-1, but no effect was observed on the 
increases elicited by bradykinin (Fig. 3C). Similarly, osmotic lysis of the lysosome-related organelles 
with 50 µM  GPN and Ca2+ depletion of acidic vesicles with 2 µM bafilomycin A1 inhibited the peak 
phase of ATP and endothelin-1, but not bradykinin-induced, Ca2+ responses (Fig. 3A, 3B and 3C).  
Reduction of the magnitude of ATP and endothelin-1-induced Ca2+ responses by Ned-19 was 
similar to that achieved by blocking the IP3-mediated Ca2+ mobilization with 100 μM 2-APB, 
although in this case the second phase of the responses were also inhibited (Fig. 5). This and the 
results with EGTA plotted in Fig. 4 suggest the involvement of three signalling pathways in the early 
phases of ATP and endothelin Ca2+  responses, which in turn, would be amplified by Ca2+ -induced 
Ca2+  release and capacitative Ca2+ entry [21,22]. On the contrary, 100 μM 8-Br-cADPR, an 
antagonist of the second messenger cADPR, had no statistically significant effect on the responses of 
ATP and endothelin-1 (Fig. 5A and B) but partly inhibited bradykinin-induced Ca2+ increases (Fig. 
5C). 
 
3.3. ATP increases NAADP levels 
Our results constitute the first report linking activation of purinergic receptors and Ca2+ release 
from acidic organelles in mammalian cells. In order to further support our data we determined 
intracellular NAADP levels after stimulation with ATP. We used a sensitive radioreceptor assay with 
a very high degree of specificity and that excludes any interference of the added ATP [6,15]. Fig. 6 
shows that 100 μM ATP stimulated the production of NAADP over time in astrocytes, whereas no 
increases were detected if Krebs buffer was added (control).  The ATP-mediated NAADP increase 
was fast and transient. These data demonstrate that NAADP is involved in the early phase of ATP-
induced Ca2+ responses. 
 
4. Discussion 
In this study we provide direct evidence that NAADP is a true intracellular second messenger in 
astrocytes. The low NAADP-AM concentrations needed to elicit a response, the bell-shaped dose-
effect curve, together with the low intracellular NAADP levels and their fast and transient increase in 
response to purinergic stimulation, agree with the NAADP signalling characteristics described in 
other cell types [4,5,10]. Interestingly, we also showed localization of the NAADP receptors in 
lysosome-related organelles and found that GPN, a disruptor of lysosome-related stores, inhibited 
most NAADP-AM-induced Ca2+ responses, suggesting that NAADP releases Ca2+  from lysosome-
related acidic vesicles.    
On the other hand, in our astrocytic cultures extracellular addition of NAADP did not always 
elicit Ca2+ responses, even at 1 mM. Responsive astrocytes did not show a bell-shaped dose-effect 
curve, and Ca2+ increases were not inhibited by the antagonist of NAADP receptors Ned-19.  Ca2+ 
increases after extracellular addition of NAADP to astrocytes have been reported previously [18,19], 
although in these studies Ca2+ responses were shown at 10 M NAADP. In both reports, NAADP-
elicited responses were heterogeneous and mediated by multiple and different signalling mechanisms. 
Moreover, Heidemann and co-workers also showed that extracellular NADP and NAAD elicited Ca2+ 
responses [18], and Singaravelu and colleagues questioned NAADP internalization in astrocytes [19]. 
Taken together all the data demonstrate that extra- and intracellular NAADP act on different 
molecular targets in glial cells.   
Importantly, we are able to link intracellular NAADP signalling to neurotransmitter-evoked Ca2+ 
signals in astrocytes and to show an agonist specific profile in Ca2+ mobilization. The coupling of 
endothelin-1 receptors to NAADP signalling has been previously described in smooth muscle cells 
[20]. Now we report, for the first time, that purinergic receptors traditionally linked to phospholipase 
C also mediate NAADP-induced Ca2+ mobilization. Our conclusions are based on pharmacological 
experiments, as well as on data obtained from a radioreceptor assay. ATP-induced NAADP synthesis 
is large, rapid, and transient, in agreement with our data showing a reduction of the initial peak phase 
of ATP-induced-Ca2+ responses caused by Ned-19, GPN and bafilomycin A1. This suggests that 
NAADP-mediated Ca2+ release is an initial event that triggers further Ca2+-induced Ca2+ responses in 
astrocytes, again a characteristic of this signalling pathway in other cell types [5]. These findings do 
not exclude other Ca2+ signalling pathways at the early phase of ATP responses, and in fact our data 
also point to the participation of IP3-mediated Ca2+  release and extracellular Ca2+ entry. In agreement, 
channel chatter between receptors situated in different intracellular Ca2+ stores has been previously 
suggested [10].  
It is worth noting that a previous report failed to detect increases in NAADP levels in response to 
ATP in whole brain cell suspensions [12], probably due to the presence of cell types other than 
cortical astrocytes, in which ATP might not be coupled to NAADP signalling. The aforementioned 
work also reported that in cultures of hippocampal glial cells, bafilomycin A1 did not reduce the 
magnitude of ATP-induced Ca2+ responses, [12] in contrast to our data showing a clear effect of 
bafilomycin A1 in ATP-mediated Ca2+  responses in cortical astrocytes.  All together, these results 
may underline regional diversity within the glial lineage in respect to the nature of Ca2+ lysosomal-
like stores and agonist recruitment of second messengers. Indeed, there is emerging data suggesting 
that astrocytes are not a homogenous cell population, and that unique characteristics of astrocytes of 
different regions may distinctly tune the neuronal activities [23]. However, one cannot exclude that 
discrepancies between our data and those reported in hippocampal astrocytes could be best explained 
by differences in the methodology used. Whereas the experiments here were performed in 
physiological-like conditions, Pandley and coworkers kept cells in Ca2+-free medium. In such 
conditions lysosome-related Ca2+ homeostasis might also be altered.  
Our results uncovering new intracellular signalling pathways linked to activation of purinergic 
receptors in astrocytes are of notable significance as ATP not only acts a main astrocyte-to-astrocyte 
messenger, but also as a unique neuron-to-glia mediator [2]. Moreover, NAADP signalling pathway 
involvement in selective neurotransmitter-induced responses demonstrates the complexity of 
astrocytic Ca2+ signalling and hence excitability. Importantly, future investigations in situ and in vivo 
based on our description of astrocytic NAADP signalling coupled to ATP signalling could shed light 
on the present debate on the role of astrocytes in synaptic transmission in vivo [24]. 
In summary, we report that NAADP is an authentic intracellular second messenger in cultured 
astrocytes and plays an important role in ATP-mediated Ca2+ signals. 
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Fig. 1. The NAADP receptor antagonist Ned-19 colocalizes with acidic vesicles. Panels (A) and 
(B) are micrographs showing vital fluorescence staining of cortical astrocytes with 500 nM 
LysoTracker Red and 100 M Ned-19, respectively; panel (C) shows the composite image. 
Colocalization of green and red pixels was quantified with ImageJ, and is shown in panel D, with 
the hottest colours indicating highest degrees of colocalization. Panel (E) shows the correlation plot 
of images shown in (A) and (B). 
Fig. 2. NAADP-AM, a cell-permeant analogue of NAADP, induces Ca2+ responses.  Cells were 
incubated with different concentrations of NAADP-AM, and Ca2+ responses were recorded. Cells 
were also pre-treated with 100 M Ned-19 or 50 µM GPN and then challenged with 100 nM 
NAADP-AM. Representative traces are shown in (A and C) and means of the increases of the Ca2+ 
concentration observed for each NAADP-AM concentration were calculated (B). Number of 
experiments analysed is indicated in parentheses, except for pre-treatment with Ned-19 and GPN, in 
which 3 and 6 experiments were performed, respectively. 
 
Fig. 3. NAADP and acidic organelles mediate ATP and endothelin-1 but not bradykinin-
induced Ca2+ responses.  Cells were challenged with agonists in the absence or in the presence of 
100 µM Ned-19, 50 µM GPN or 2 µM bafilomycin A1 (Baf A1), and Ca2+ responses were induced 
by 100 µM ATP (A),  10 nM endothelin (ET-1) (B) or 1 µM bradykinin (BK) (C). Representative 
traces are shown on the left side of the figure. Middle panels show the means of  the maximum ratio 
increase over basal Ca2+ concentrations as percentage of its respective control (ratio increase over 
basal Ca2+ concentrations induced by the agonist). Right panels show means of plateau responses 
(increase of Ca2+ concentrations at 3 minutes over basal Ca2+ concentrations) as percentage of their 
respective peak responses (the initial increase over basal Ca2+ concentrations). The number of 
experiments performed is indicated in parentheses. Statistics: *** P<0.001, two-tailed t test. 
 
Fig. 4. Ca2+ responses induced by ATP, endothelin-1 and bradykinin in the presence of 
EGTA. Cells were stimulated with 100 µM ATP,  10 nM endothelin (ET-1) or 1 µM bradykinin 
(BK) in the presence of EGTA, a calcium chelator, to inhibit extracellular Ca2+ entry. Responses are 
reduced and above all, more transient. 
 
Fig. 5. ATP, endothelin-1 and bradykinin release Ca2+ from the endoplasmic reticulum.  Cells 
were challenged with agonists in the absence or in the presence of an antagonist of IP3 receptors 
(100 µM 2-APB) or an antagonist of cADPR signalling (100 µM 8-Br-cADPR). Panels (A), (B) 
and (C) show Ca2+ responses induced by 100 µM ATP,  10 nM endothelin (ET-1) and 1 µM 
bradykinin (BK), respectivetly. Representative traces are shown on the left side of the figure. 
Middle panels show the means of  the maximum ratio increase over basal Ca2+ concentrations as 
percentage of its respective control (ratio increase over basal Ca2+ concentrations induced by the 
agonist). Right panels show means of plateau responses (increase of Ca2+ concentrations at 3 
minutes over basal Ca2+ concentrations) as percentage of their respective peak responses (the 
initial increase over basal Ca2+ concentrations). The number of experiments performed is indicated 
in parentheses. Statistics: *P<0.05 and ***P<0.001, two-tailed t test. 
 
Fig. 6. ATP increases intracellular NAADP levels. 32P-NAADP was used in a competitive assay 
to determine the endogenous NAADP levels at rest conditions (dotted line) and upon stimulation 
with 100 µM ATP (solid line). Values are means ± SEM (n=8) normalized to the absolute level of 






Fig. S1. Extracellular NAADP-induced Ca2+ responses. Cells were incubated with different 
concentrations of NAADP added extracellularly and Ca2+ responses were recorded. In some 
experiments, 100 µM Ned-19 was applied 20 minutes before NAADP addition (C). 
Representative traces are shown in (A and C) and means of the increases of the Ca2+ 
concentration observed for each NAADP-AM concentration were calculated (B). Number of 
responding cells of at least 3 independent experiments is indicated in parentheses. Depending on 
the culture, two different responses of 1 mM NAADP were obtained, and both are shown. Data 
obtained in the presence of  Ned-19 correspond to cells from cultures that showed high Ca2+ 
increases at 1mM NAADP. 
 
 







